Considering the substantial body of existing evidence supporting the essential roles of higher vitamin D status [serum 25(OH)D levels] in reducing insulin resistance and maintaining adequate insulin secretory responses, and causing prospective reductions in T2DM risk with higher baseline vitamin D levels. This evidence concerns the gene INS and Insulin resistance.